191 related articles for article (PubMed ID: 1282590)
1. Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle.
Yang T; Tande PM; Refsum H
J Cardiovasc Pharmacol; 1992 Dec; 20(6):889-94. PubMed ID: 1282590
[TBL] [Abstract][Full Text] [Related]
2. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle.
Marschang H; Beyer T; Karolyi L; Kübler W; Brachmann J
Cardiovasc Drugs Ther; 1998 Dec; 12(6):573-83. PubMed ID: 10410827
[TBL] [Abstract][Full Text] [Related]
3. Effects of altered extracellular potassium and pacing cycle length on the class III antiarrhythmic actions of dofetilide (UK-68,798) in guinea-pig papillary muscle.
Yang T; Tande PM; Lathrop DA; Refsum H
Cardiovasc Drugs Ther; 1992 Aug; 6(4):429-36. PubMed ID: 1520650
[TBL] [Abstract][Full Text] [Related]
4. Effects of EGIS-7229 (S 21407), a novel class III antiarrhythmic drug, on myocardial refractoriness to electrical stimulation in vivo and in vitro.
Kovács A; Gyönös I; Magyar J; Bányász T; Nánási PP; Spedding M; Szénási G
J Cardiovasc Pharmacol; 2001 Jan; 37(1):78-88. PubMed ID: 11152377
[TBL] [Abstract][Full Text] [Related]
5. Class III antiarrhythmic action by potassium channel blockade: dofetilide attenuates hypoxia induced electromechanical changes.
Yang T; Tande PM; Lathrop DA; Refsum H
Cardiovasc Res; 1992 Nov; 26(11):1109-15. PubMed ID: 1291089
[TBL] [Abstract][Full Text] [Related]
6. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium.
Tande PM; Bjørnstad H; Yang T; Refsum H
J Cardiovasc Pharmacol; 1990 Sep; 16(3):401-10. PubMed ID: 1700210
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
[TBL] [Abstract][Full Text] [Related]
8. Recording of transmembrane action potentials in chronic ischemic heart disease and dilated cardiomyopathy and the effects of the new class III antiarrhythmic agents D-sotalol and dofetilide.
Montero M; Schmitt C
J Cardiovasc Pharmacol; 1996 Apr; 27(4):571-7. PubMed ID: 8847875
[TBL] [Abstract][Full Text] [Related]
9. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
Nakaya H; Tohse N; Takeda Y; Kanno M
Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
[TBL] [Abstract][Full Text] [Related]
10. Class III effects of dofetilide and arrhythmias are modulated by [K+]o in an in vitro model of simulated-ischemia and reperfusion in guinea-pig ventricular myocardium.
Ducroq J; Rouet R; Sallé L; Puddu PE; Repessé Y; Ghadanfar M; Ducouret P; Gérard JL
Eur J Pharmacol; 2006 Feb; 532(3):279-89. PubMed ID: 16480976
[TBL] [Abstract][Full Text] [Related]
11. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
[TBL] [Abstract][Full Text] [Related]
12. KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium.
Lee K; Lee JY; Kim HY; Kwon LS; Shin HS; Tanabe S; Kozono T; Park SD; Chung YS
J Cardiovasc Pharmacol; 1998 Apr; 31(4):609-17. PubMed ID: 9554812
[TBL] [Abstract][Full Text] [Related]
13. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
MacKenzie I; Saville VL; Waterfall JF
Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of increased extracellular potassium and pacing frequency on the class III activities of methanesulfonanilide IKr blockers dofetilide, D-sotalol, E-4031, and MK-499.
Baskin EP; Lynch JJ
J Cardiovasc Pharmacol; 1994 Aug; 24(2):199-208. PubMed ID: 7526051
[TBL] [Abstract][Full Text] [Related]
15. Comparison of binding to rapidly activating delayed rectifier K+ channel, IKr, and effects on myocardial refractoriness for class III antiarrhythmic agents.
Lynch JJ; Baskin EP; Nutt EM; Guinosso PJ; Hamill T; Salata JJ; Woods CM
J Cardiovasc Pharmacol; 1995 Feb; 25(2):336-40. PubMed ID: 7752661
[TBL] [Abstract][Full Text] [Related]
16. Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
Kovács A; Magyar J; Bányász T; Nánási PP; Szénási G
Br J Pharmacol; 2003 Aug; 139(8):1555-63. PubMed ID: 12922944
[TBL] [Abstract][Full Text] [Related]
17. Effects of new and potent methanesulfonanilide class III antiarrhythmic agents on myocardial refractoriness and contractility in isolated cardiac muscle.
Baskin EP; Serik CM; Wallace AA; Brookes LM; Selnick HG; Claremon DA; Lynch JJ
J Cardiovasc Pharmacol; 1991 Sep; 18(3):406-14. PubMed ID: 1720841
[TBL] [Abstract][Full Text] [Related]
18. Proarrhythmic effects of DL- and D-sotalol on the "border zone" between normal and ischemic regions of isolated ventricular myocardium and antiarrhythmic effects on reperfusion.
Picard S; Rouet R; Monti F; Puddu PE; Ducouret P; Flais F; Libersa C; Gérard JL
J Cardiovasc Pharmacol; 1998 Jan; 31(1):126-39. PubMed ID: 9456287
[TBL] [Abstract][Full Text] [Related]
19. Membrane activity of class III antiarrhythmic compounds; a comparison between ibutilide, d-sotalol, E-4031, sematilide and dofetilide.
Lee KS; Tsai TD; Lee EW
Eur J Pharmacol; 1993 Mar; 234(1):43-53. PubMed ID: 8472760
[TBL] [Abstract][Full Text] [Related]
20. Electropharmacology of dofetilide, a new class III agent, in anaesthetised dogs.
Gwilt M; Blackburn KJ; Burges RA; Higgins AJ; Milne AA; Solca AM
Eur J Pharmacol; 1992 May; 215(2-3):137-44. PubMed ID: 1396982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
